Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0JSY stock hub

LON/0JSY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0JSYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.3B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0JSY

In the news

Latest news · LON/0JSY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.8

P25 12.9P50 16.9P75 23.5

Trailing P/E21.4

P25 15.9P50 22.9P75 35.8

ROE11

P25 -54.2P50 2.1P75 13.7

ROIC8.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0JSY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	66,385
Employees Change	1,000%
Employees Change Percent	1.43
Enterprise value	$19.9B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US5049221055
Last refreshed	2026-05-10
Market cap	$15.3B
Price	$254
Price currency	USD
Rev Per Employee	161,353.82x
Sector	Healthcare
Sic	8071
Symbol	lon/0JSY
Website	https://www.labcorp.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.66%
EV Earnings	27.96x
EV/EBIT	17.62x
EV/EBITDA	10.69x
EV/FCF	19.02x
EV/Sales	1.92x
FCF yield	6.85%
Forward P/E	13.84x
P/B ratio	2.31x
P/E ratio	21.45x
P/S ratio	1.43x
PE Ratio10 Y	21.93x
PE Ratio3 Y	31.56x
PE Ratio5 Y	24.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.03%
EBITDA Margin	15.93%
FCF margin	9.78%
Gross margin	28.83%
Gross Profit	$3.1B
Gross Profit Growth	10.97%
Gross Profit Growth Q	6.94%
Gross Profit Growth3 Y	5.46%
Gross Profit Growth5 Y	-6.88%
Net Income	$713M
Net Income Growth	28.83%
Net Income Growth Q	30.55%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Net Income Growth3 Y	-2%
Net Income Growth5 Y	-18.65%
Pretax Margin	8.14%
Profit Margin	6.66%
Profit Per Employee	$10,740
Profitable Years	14
ROA	5.31
Roa5y	5.62
ROCE	9.48
ROE	11.05
Roe5y	11.24
ROIC	8.6
Roic5y	9.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.92%
Cagr3y	11.39%
Cagr5y	2.26%
Div CAGR3	-3.41%
EPS Growth	30.21
EPS Growth Q	32.94
EPS Growth Quarters	4
EPS Growth Years	2
EPS Growth3 Y	0.64
EPS Growth5 Y	-15.94
FCF Growth	20.14%
FCF Growth3 Y	7.24%
FCF Growth5 Y	-12.63%
OCF Growth	10.98%
OCF Growth Q	935.14%
OCF Growth10 Y	4.24%
OCF Growth3 Y	6.23%
OCF Growth5 Y	-10.1%
Revenue Growth	7.34x
Revenue Growth Q	5.76x
Revenue Growth Quarters	8x
Revenue Growth Years	3x
Revenue Growth3 Y	6.36x
Revenue Growth5 Y	-1.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.77
Assets	$14.5B
Cash	$743M
Current Assets	$3.3B
Current Liabilities	$1.9B
Debt	$5.5B
Debt EBITDA	$2.85
Debt Equity	$0.83
Debt FCF	$5.27
Equity	$6.6B
Interest Coverage	6.99
Liabilities	$7.8B
Long Term Assets	$11.1B
Long Term Liabilities	$5.9B
Net Cash	$-4.8B
Net Cash By Market Cap	$-31.26
Net Debt EBITDA	$2.8
Net Debt Equity	$0.72
Net Debt FCF	$4.56
Tangible Book Value	$-1.4B
Tangible Book Value Per Share	$-17.14
WACC	7.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.73
Inventory Turnover	20.42
Net Working Capital	$1.2B
Quick ratio	1.3
Working Capital	$1.5B
Working Capital Turnover	$5.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.01%
Dividend Growth	-4.89%
Dividend Growth Years	0%
Dividend per share	$2.15
Dividend Years	5
Dividend Yield	0.84%
Ex Div Date	2026-02-27
Last Dividend	$0.53
Payout Frequency	Quarterly
Payout Ratio	25.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.91%
200-day SMA	268.7
3Y total return	38.24%
50-day SMA	268
50-day SMA vs 200-day SMA	50under200
5Y total return	11.82%
All Time High	314.2
All Time High Change	-19.08%
All Time High Date	2021-12-30
All Time Low	105.8
All Time Low Change	140.3%
All Time Low Date	2020-03-23
ATR	7.14
Beta	0.88
Ch YTD	0.91
High	260
High52	297.3
High52 Date	2026-02-17
High52ch	-14.48%
Low	254.3
Low52	238.9
Low52 Date	2025-05-22
Low52ch	6.42%
Ma50ch	-5.13%
Price vs 200-day SMA	-5.39%
RSI	38.67
RSI Monthly	50.79
RSI Weekly	43.1
Sharpe ratio	0.26x
Sortino ratio	0.61
Total Return	1.85%
Tr YTD	1.17
Tr1m	-6.46%
Tr1w	-0.71%
Tr3m	-7.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$1.2B
Operating Income Growth	36.64
Operating Income Growth Q	16.49
Operating Income Growth3 Y	1.73
Operating Income Growth5 Y	-16.43
Operating margin	11.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,596,940%
Net Borrowing	550,135,500
Shares Insiders	0.4%
Shares Institutions	104.86%
Shares Qo Q	-0.36%
Shares Yo Y	-1.01%
Short Ratio	4.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$953.7M
Average Volume	257.05x
Bv Per Share	80.32
CAPEX	$-325.3M
Ch1m	-6.46
Ch1w	-0.71
Ch1y	2.81
Ch3m	-7.83
Ch3y	14.33
Ch5y	-8.58
Ch6m	2.17
Change	-1.45%
Change From Open	-2.21
Close	258
Days Gap	0.78
Depreciation Amortization	508,398,553.4
Dollar Volume	1,271.3
Earnings Date	2026-04-30
EBIT	$1.2B
EBITDA	$1.7B
EPS	$8.55
F Score	5
FCF	$1B
FCF EV Yield	5.26x
Financing CF	-27,868,824
Fiscal Year End	December
Founded	1,995
Goodwill	5,101,736,572.8
Graham Number	171.38186
Graham Upside	-32.6
Income Tax	$158.5M
Investing CF	-893,695,631
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$59.27
Lynch Upside	-76.69
Ma150	267.9
Ma150ch	-5.08%
Ma20	262.8
Ma20ch	-3.25%
Net CF	463,243,469
Open	260
P FCF Ratio	14.59
P OCF Ratio	11.13
Payment Date	2026-03-12
Position In Range	0
Ppne	2,248,587,167
Price Date	2026-05-08
Price EBITDA	$8.96
Relative Volume	0.02x
Revenue	10,711,473,381x
SBC By Revenue	0.88x
Share Based Comp	94,435,934
Tax By Revenue	1.48x
Tax Rate	18.17%
Tr6m	2.71%
Volume	5
Z Score	3.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0JSY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$2.15 annual per share

Payout ratio

+25.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-02-27

Performance

LON/0JSY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0JSY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+104.9%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0JSY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.7

Neutral momentum band

Price vs 200-day MA

-5.4%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0JSY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0JSY stock rating?

lon/0JSY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0JSY analysis?

The full report lives at /stocks/lon/0JSY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0JSY?

The latest report frames lon/0JSY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0JSY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.